---
document_datetime: 2023-09-21 18:12:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/izba-epar-all-authorised-presentations_en.pdf
document_name: izba-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7832967
conversion_datetime: 2025-12-28 08:22:02.02083
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/13/905/001  | Izba              | 30 µg/ml   | Eye drops, solution   | Ocular use                | bottle (PP)           | 2.5 ml                    | 1 bottle    |
| EU/1/13/905/002  | Izba              | 30 µg/ml   | Eye drops, solution   | Ocular use                | bottle (PP)           | 2.5 ml                    | 3 bottles   |